These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 14966727)

  • 1. Hepatocyte growth factor treatment ameliorates diarrhea and bowel inflammation in a rat model of inflammatory bowel disease.
    Arthur LG; Schwartz MZ; Kuenzler KA; Birbe R
    J Pediatr Surg; 2004 Feb; 39(2):139-43; discussion 139-43. PubMed ID: 14966727
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Hepatocyte growth factor ameliorates inflammatory bowel disease in a rat model.
    Arthur LG; Kuenzler KA; Schwartz MZ
    J Gastrointest Surg; 2003 Dec; 7(8):1062-8; discsussion 1068. PubMed ID: 14675716
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Glucagonlike peptide-2 analogue: a possible new approach in the management of inflammatory bowel disease.
    Arthur GL; Schwartz MZ; Kuenzler KA; Birbe R
    J Pediatr Surg; 2004 Mar; 39(3):448-52; discussion 448-52. PubMed ID: 15017568
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Growth factor manipulation of intestinal angiogenesis: a possible new paradigm in the management of inflammatory bowel disease.
    Thatch KA; Mendelson KG; Haber MM; Schwartz MZ
    J Surg Res; 2009 Oct; 156(2):245-9. PubMed ID: 19524260
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Treatment of inflammatory bowel disease in a rodent model with the intestinal growth factor glucagon-like peptide-2.
    Alavi K; Schwartz MZ; Palazzo JP; Prasad R
    J Pediatr Surg; 2000 Jun; 35(6):847-51. PubMed ID: 10873024
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Gene alterations and intestinal mucosal changes following growth factor and omega-3 exposure in a rat model of inflammatory bowel disease.
    Katz MS; Thatch KA; Schwartz MZ
    J Pediatr Surg; 2013 Feb; 48(2):345-52. PubMed ID: 23414863
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hepatocyte growth factor and omega-3-enriched feeds have a synergistic effect on mucosal mass in an animal model of inflammatory bowel disease.
    Katz MS; Thatch KA; Schwartz MZ
    J Pediatr Surg; 2012 Jan; 47(1):194-8. PubMed ID: 22244416
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of hepatocyte growth factor on rat inflammatory bowel disease models.
    Ohda Y; Hori K; Tomita T; Hida N; Kosaka T; Fukuda Y; Miwa H; Matsumoto T
    Dig Dis Sci; 2005 May; 50(5):914-21. PubMed ID: 15906768
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hepatocyte growth factor enhances intestinal mucosal cell function and mass in vivo.
    Kato Y; Yu D; Lukish JR; Schwartz MZ
    J Pediatr Surg; 1997 Jul; 32(7):991-4. PubMed ID: 9247219
    [TBL] [Abstract][Full Text] [Related]  

  • 10. IL-11, a pleiotropic cytokine: exciting new effects of IL-11 on gastrointestinal mucosal biology.
    Keith JC; Albert L; Sonis ST; Pfeiffer CJ; Schaub RG
    Stem Cells; 1994; 12 Suppl 1():79-89; discussion 89-90. PubMed ID: 7696971
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of murine recombinant interleukin-10 on the inflammatory disease of rats transgenic for HLA-B27 and human beta 2-microglobulin.
    Bertrand V; Quéré S; Guimbaud R; Sogni P; Chauvelot-Moachon L; Tulliez M; Lamarque D; Charreire J; Giroud JP; Couturier D; Chaussade S; Breban M
    Eur Cytokine Netw; 1998 Jun; 9(2):161-70. PubMed ID: 9681392
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Enhancement of intestinal adaptation by hepatocyte growth factor.
    Kato Y; Yu D; Schwartz MZ
    J Pediatr Surg; 1998 Feb; 33(2):235-9. PubMed ID: 9498393
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Influence of luminal hepatocyte growth factor on small intestine mucosa in vivo.
    Kato Y; Yu D; Lukish JR; Schwartz MZ
    J Surg Res; 1997 Jul; 71(1):49-53. PubMed ID: 9271277
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Growth factor modulation of hepatic inflammation: a novel approach to the management of total parenteral nutrition-associated liver disease.
    Thatch KA; Katz MS; Haber MM; Schwartz MZ
    J Pediatr Surg; 2010 Jan; 45(1):89-94. PubMed ID: 20105586
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pharmacogenomic analysis of rhIL-11 treatment in the HLA-B27 rat model of inflammatory bowel disease.
    Peterson RL; Wang L; Albert L; Marchese E; Erickson J; Wong A; Mounts WM; Hayes L; Bouchard P; Keith J; Dorner AJ
    Pharmacogenomics J; 2002; 2(6):383-99. PubMed ID: 12629504
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Increased tissue protein synthesis during spontaneous inflammatory bowel disease in HLA-B27 rats.
    El Yousfi M; Breuillé D; Papet I; Blum S; André M; Mosoni L; Denis P; Buffière C; Obled C
    Clin Sci (Lond); 2003 Oct; 105(4):437-46. PubMed ID: 12793856
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mucosal repair and growth factors: recombinant human hepatocyte growth factor as an innovative therapy for inflammatory bowel disease.
    Ido A; Numata M; Kodama M; Tsubouchi H
    J Gastroenterol; 2005 Oct; 40(10):925-31. PubMed ID: 16261428
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Beneficial effects of estrogen treatment in the HLA-B27 transgenic rat model of inflammatory bowel disease.
    Harnish DC; Albert LM; Leathurby Y; Eckert AM; Ciarletta A; Kasaian M; Keith JC
    Am J Physiol Gastrointest Liver Physiol; 2004 Jan; 286(1):G118-25. PubMed ID: 12958017
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Evaluation of hepatocyte growth factor as a local acute phase response marker in the bowel: the clinical impact of a rapid diagnostic test for immediate identification of acute bowel inflammation.
    Sorour AE; Lönn J; Nakka SS; Nayeri T; Nayeri F
    Cytokine; 2015 Jan; 71(1):8-15. PubMed ID: 25174881
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Enteral glutamine does not enhance the effects of hepatocyte growth factor in short bowel syndrome.
    Alavi K; Kato Y; Yu D; Schwartz MZ
    J Pediatr Surg; 1998 Nov; 33(11):1666-9. PubMed ID: 9856891
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.